(0.31%) 5 115.83 points
(0.31%) 38 359 points
(0.34%) 15 982 points
(-0.87%) $83.12
(5.77%) $2.03
(0.38%) $2 356.20
(0.48%) $27.67
(4.04%) $959.35
(-0.21%) $0.933
(-0.38%) $10.98
(-0.54%) $0.796
(1.69%) $93.43
3 days till quarter result
(amc 2024-05-02)
Expected move: +/- 3.80%
@ $59.59
発行日: 14 2月 2024 @ 23:44
リターン: 11.05%
前回のシグナル: 2月 13 - 23:30
前回のシグナル:
リターン: -2.22 %
Live Chart Being Loaded With Signals
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide...
Stats | |
---|---|
本日の出来高 | 43 959.00 |
平均出来高 | 119 669 |
時価総額 | 1.48B |
EPS | $0 ( 2024-02-27 ) |
次の収益日 | ( $0.390 ) 2024-05-02 |
Last Dividend | $0.140 ( 2023-11-15 ) |
Next Dividend | $0 ( N/A ) |
P/E | 49.38 |
ATR14 | $0.110 (0.17%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-28 | Shadan Martha | Buy | 1 | Dividend Equivalent Rights |
2024-03-28 | Shadan Martha | Buy | 1 | Dividend Equivalent Rights |
2024-03-28 | Shadan Martha | Buy | 1 | Dividend Equivalent Rights |
2024-03-28 | Roush John A | Buy | 0 | Dividend Equivalent Rights |
2024-03-28 | Roush John A | Buy | 1 | Dividend Equivalent Rights |
INSIDER POWER |
---|
-54.44 |
Last 100 transactions |
Buy: 60 276 | Sell: 205 052 |
ボリューム 相関
LeMaitre Vascular Inc 相関
10 最も正の相関 | |
---|---|
CIFR | 0.931 |
WINA | 0.93 |
PERI | 0.925 |
CDNS | 0.922 |
NVDA | 0.921 |
CPRT | 0.918 |
LMRKO | 0.917 |
LIBY | 0.915 |
NAAC | 0.914 |
OMAB | 0.913 |
10 最も負の相関 | |
---|---|
WTBA | -0.927 |
ALRS | -0.922 |
GNTY | -0.921 |
IPA | -0.914 |
BWB | -0.912 |
TRMK | -0.911 |
TRIT | -0.91 |
GSMG | -0.906 |
FVCB | -0.902 |
WASH | -0.901 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
LeMaitre Vascular Inc 相関 - 通貨/商品
LeMaitre Vascular Inc 財務諸表
Annual | 2023 |
収益: | $193.48M |
総利益: | $120.96M (62.52 %) |
EPS: | $1.360 |
FY | 2023 |
収益: | $193.48M |
総利益: | $120.96M (62.52 %) |
EPS: | $1.360 |
FY | 2022 |
収益: | $161.65M |
総利益: | $104.90M (64.89 %) |
EPS: | $0.940 |
FY | 2021 |
収益: | $154.42M |
総利益: | $101.38M (65.65 %) |
EPS: | $1.270 |
Financial Reports:
No articles found.
LeMaitre Vascular Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.125 (N/A) |
$0.125 (N/A) |
$0.140 (N/A) |
$0.140 (N/A) |
$0.140 (N/A) |
$0.140 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0200 | 2011-03-18 |
Last Dividend | $0.140 | 2023-11-15 |
Next Dividend | $0 | N/A |
Payout Date | 2023-11-30 | |
Next Payout Date | N/A | |
# dividends | 52 | -- |
Total Paid Out | $3.50 | -- |
Avg. Dividend % Per Year | 0.74% | -- |
Score | 5.01 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.18 | |
Div. Directional Score | 8.99 | -- |
Year | Amount | Yield |
---|---|---|
2011 | $0.0800 | 1.15% |
2012 | $0.100 | 1.74% |
2013 | $0.120 | 2.08% |
2014 | $0.140 | 1.75% |
2015 | $0.160 | 2.05% |
2016 | $0.180 | 1.14% |
2017 | $0.220 | 0.87% |
2018 | $0.280 | 0.90% |
2019 | $0.340 | 1.45% |
2020 | $0.380 | 1.06% |
2021 | $0.440 | 1.09% |
2022 | $0.500 | 0.97% |
2023 | $0.560 | 1.23% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.156 | 1.500 | 6.89 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0868 | 1.200 | 7.11 | 8.53 | [0 - 0.3] |
returnOnEquityTTM | 0.105 | 1.500 | 9.94 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.413 | -1.000 | 5.87 | -5.87 | [0 - 1] |
currentRatioTTM | 6.32 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 4.36 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 0.812 | 1.500 | 6.60 | 9.90 | [0.2 - 2] |
debtRatioTTM | 0.0551 | -1.500 | 9.08 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -256.36 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.650 | 2.00 | 9.45 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.324 | 2.00 | 9.34 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0641 | -1.500 | 9.74 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.649 | 1.000 | 2.52 | 2.52 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.189 | 1.000 | 8.21 | 8.21 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.925 | 1.000 | 0.419 | 0.419 | [0.2 - 2] |
assetTurnoverTTM | 0.558 | 0.800 | 9.61 | 7.69 | [0.5 - 2] |
Total Score | 10.81 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 48.44 | 1.000 | 5.21 | 0 | [1 - 100] |
returnOnEquityTTM | 0.105 | 2.50 | 9.96 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.324 | 2.00 | 9.56 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.886 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.650 | 2.00 | 9.45 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.413 | 1.500 | 5.87 | -5.87 | [0 - 1] |
pegRatioTTM | 3.39 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.190 | 1.000 | 7.75 | 0 | [0.1 - 0.5] |
Total Score | 7.18 |
LeMaitre Vascular Inc
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。